Increased iron deposition of deep cerebral gray matter structures in hemodialysis patients: A longitudinal study using quantitative susceptibility mapping

The cerebral iron overload in hemodialysis patients has been reported in a previous study, in which the evaluation of the changes in iron content could be affected by the cross‐sectional analysis.

[1]  Stephen M Smith,et al.  Fast robust automated brain extraction , 2002, Human brain mapping.

[2]  Saifeng Liu,et al.  Quantitative measurements of brain iron deposition in cirrhotic patients using susceptibility mapping , 2015, Acta radiologica.

[3]  David A. Drew,et al.  Frequency of and risk factors for poor cognitive performance in hemodialysis patients , 2013, Neurology.

[4]  M. Pandey,et al.  Role of kidney biomarkers of chronic kidney disease: An update. , 2014, Saudi journal of biological sciences.

[5]  Ferdinand Schweser,et al.  Quantitative imaging of intrinsic magnetic tissue properties using MRI signal phase: An approach to in vivo brain iron metabolism? , 2011, NeuroImage.

[6]  E. Haacke,et al.  Assessing global and regional iron content in deep gray matter as a function of age using susceptibility mapping , 2016, Journal of magnetic resonance imaging : JMRI.

[7]  M. Nakayama,et al.  Cerebro-renal interactions: impact of uremic toxins on cognitive function. , 2014, Neurotoxicology.

[8]  Xiaojun Xu,et al.  Age, gender, and hemispheric differences in iron deposition in the human brain: An in vivo MRI study , 2008, NeuroImage.

[9]  Jean-Francois Mangin,et al.  R2* mapping for brain iron: associations with cognition in normal aging , 2015, Neurobiology of Aging.

[10]  D. Girelli,et al.  Evidence for tissue iron overload in long‐term hemodialysis patients and the impact of withdrawing parenteral iron , 2012, European Journal of Haematology.

[11]  Akira Watanabe.  Cerebral microbleeds and intracerebral hemorrhages in patients on maintenance hemodialysis. , 2007, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[12]  D. Molloy,et al.  Standardized Mini-Mental State Examination. Use and interpretation. , 2001, Canadian family physician Medecin de famille canadien.

[13]  E. Haacke,et al.  Quantitative susceptibility mapping: current status and future directions. , 2015, Magnetic resonance imaging.

[14]  F. Eitner,et al.  Clinical predictors of individual cognitive fluctuations in patients undergoing hemodialysis. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[15]  Robert Turner,et al.  Toward in vivo histology: A comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2 ⁎-imaging at ultra-high magnetic field strength , 2013, NeuroImage.

[16]  Rohit Bakshi,et al.  Iron in chronic brain disorders: Imaging and neurotherapeutic implications , 2007, Neurotherapeutics.

[17]  E. Haacke,et al.  Imaging iron stores in the brain using magnetic resonance imaging. , 2005, Magnetic resonance imaging.

[18]  Y. Cheng,et al.  Susceptibility mapping as a means to visualize veins and quantify oxygen saturation , 2010, Journal of magnetic resonance imaging : JMRI.

[19]  Jun Liu,et al.  Investigation of cerebral iron deposition in aged patients with ischemic cerebrovascular disease using susceptibility-weighted imaging , 2016, Therapeutics and clinical risk management.

[20]  W H Oldendorf,et al.  Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores , 1993, Magnetic resonance in medicine.

[21]  John F Schenck,et al.  Magnetic resonance imaging of brain iron , 2003, Journal of the Neurological Sciences.

[22]  I. Kutyrina,et al.  [Risk factors for cardiovascular system damage in chronic kidney disease]. , 2013, Terapevticheskii arkhiv.

[23]  S. Ropele,et al.  Quantitative MR imaging of brain iron: a postmortem validation study. , 2010, Radiology.

[24]  Torsten Rohlfing,et al.  MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping , 2011, NeuroImage.

[25]  M. Selim,et al.  Brain iron deposition in white matter hyperintensities: a 3-T MRI study , 2012, AGE.

[26]  Yan Zhou,et al.  Characterizing Brain Iron Deposition in Patients with Subcortical Vascular Mild Cognitive Impairment Using Quantitative Susceptibility Mapping: A Potential Biomarker , 2017, Front. Aging Neurosci..

[27]  Ayman Karkar,et al.  Modalities of hemodialysis: quality improvement. , 2012, Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.

[28]  T. Luo,et al.  Iron deposition of the deep grey matter in patients with multiple sclerosis and neuromyelitis optica: a control quantitative study by 3D-enhanced susceptibility-weighted angiography (ESWAN). , 2012, European Journal of Radiology.

[29]  William Molloy,et al.  Standardized Mini-Mental State Examination. Use and interpretation. , 2001, Canadian family physician Medecin de famille canadien.

[30]  Increased brain iron deposition is a risk factor for brain atrophy in patients with haemodialysis: a combined study of quantitative susceptibility mapping and whole brain volume analysis , 2015, Metabolic Brain Disease.

[31]  Faith M. Gunning-Dixon,et al.  Differential aging of the human striatum: longitudinal evidence. , 2003, AJNR. American journal of neuroradiology.

[32]  J. Schenck,et al.  High‐field magnetic resonance imaging of brain iron: birth of a biomarker? , 2004, NMR in biomedicine.

[33]  Xiao-er Wei,et al.  Using susceptibility-weighted images to quantify iron deposition differences in amnestic mild cognitive impairment and Alzheimer's disease. , 2013, Neurology India.

[34]  Grace H. Lee,et al.  The fascinating but deceptive ferritin: to measure it or not to measure it in chronic kidney disease? , 2006, Clinical journal of the American Society of Nephrology : CJASN.

[35]  Francis Lilley,et al.  Fast and robust three-dimensional best path phase unwrapping algorithm. , 2007, Applied optics.

[36]  M. Valko,et al.  Advances in metal-induced oxidative stress and human disease. , 2011, Toxicology.

[37]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[38]  E. Haacke,et al.  Quantitative measurement of brain iron deposition in patients with haemodialysis using susceptibility mapping , 2014, Metabolic Brain Disease.

[39]  Andreas Schäfer,et al.  High resolution magnetic susceptibility mapping of the substantia nigra in Parkinson's disease , 2012, Journal of magnetic resonance imaging : JMRI.

[40]  Joseph Jankovic,et al.  Neurodegenerative disease and iron storage in the brain , 2004, Current opinion in neurology.